AMRECIBART
UNII ZDR9VW2WMN

Substance Identification & Data

This profile provides standardized clinical and technical data for Amrecibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZDR9VW2WMN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3008610-20-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ZDR9VW2WMN
CAS Registry Number
3008610-20-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AMRECIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C214499
National Cancer Institute reference terminology for clinical and research data.
INN ID
13412
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amrecibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AMRECIBART

Common Names & Synonyms

AMRECIBART [INN]
IMMUNOGLOBULIN G4 (231-PROLINE), ANTI-(HUMAN BLOOD-COAGULATION FACTOR XI) (HUMAN MONOCLONAL REGN9933 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN9933 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus